Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Union research programme receives 7% boost:

This article was originally published in Clinica

Executive Summary

Funding of the European Union's Fourth Framework Research programme, which includes Ecu 888 million ($668 million) for biotechnology, biomedicine and health, is to receive a 7% top- up to Ecu 13,160 million due to the recent expansion of the Union to include Austria, Finland and Sweden. The increase was agreed at the European Parliament's July session in Strasbourg where another more contentious issue was debated concerning the level of additional funding to be allocated when the four-year programme is subjected to mid-term review in 1997.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT092466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel